By analyzing the structure of the after the C-terminal domain of a breast cancer susceptibility protein (BRCT) in H2A.X, scientists have found that tyrosine 142 residue (Y142) was its terminal residue and had crucial effect on the binding of H2A.X to MDC1 (26). The gene discussed is MDC1; the disease is cancer.